With pharmaceutical drug delivery innovations like reusable autoinjectors becoming more advanced from almost every angle, successful commercialization is increasingly complex. Our compact, powerful, reusable and adaptable Aria Smart Autoinjector platform is aligned to emerging global trends—and designed for ease of use. Read about it and several other two-step disposable mechanical devices in the September 2023 Drug Development & Delivery special feature entitled, “46 Injection Devices: Designing in Sustainability, Usability & Digitization for Patient Compliance.” Phillips-Medisize Commercial Directors Iain Simpson and Tony Bedford are both quoted as they consider key design factors related to performance, practicality, patient-centered care and more.
Scaling the Everest of Cell & Gene Therapy
Our Aria smart autoinjector is a powerful, flexible, platform, designed for ease of use with a compact form and aligned to key emerging global trends:
- Shifting of healthcare out of hospitals
- Ready for the connected world
- More sustainable solutions
Advanced Medical Innovation, Design and Production
The future is rich with potential for medical technology — and a better, connected patient experience is at the center of it. Improving lives by bringing more advanced care closer to home is not only possible but emerging rapidly.
For decades, Phillips-Medisize, a Molex company, has been laser focused on contract design and manufacturing of products in highly regulated industries such as Pharmaceuticals, where precision, reliability and quality are critical.
Exact Sciences and Phillips-Medisize Collaborate to Fight Colorectal Cancer
Exact Sciences, a leader in cancer testing, developed a game-changing at-home colorectal cancer kit, but needed support to build the highest quality product. With decades of manufacturing innovation for healthcare and life sciences companies, Exact Sciences found a quality-first collaborator in Phillips-Medisize.